Jennifer L. Davis's Insider Trades & SAST Disclosures
Jennifer L. Davis's most recent trade in Abbvie Inc was a trade of 1,203 Common Stock, $0.01 par value done . Disclosure was reported to the exchange on May 9, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jennifer L. Davis.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc | Jennifer L. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,203 | 2,525 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 161.38 per share. | 29 Apr 2025 | 1,000 | 51,964 (0%) | 0% | 161.4 | 161,384 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 22 | 179 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Davis L. Jennifer | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 170.78 per share. | 19 Dec 2024 | 46 | 52,963 (0%) | 0% | 170.8 | 7,856 | Common Stock |
| Procter & Gamble Co. | Jennifer Davis L. | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2024 | 46 | 736 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.78 per share. | 19 Dec 2024 | 46 | 52,917 (0%) | 0% | 170.8 | 7,856 | Common Stock |
| Procter & Gamble Co. | L. Davis Jennifer | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 21 | 157 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 56,554 | 56,554 | - | - | Stock Option (Right to Buy) | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 171.65 per share. | 01 Oct 2024 | 4,447 | 52,872 (0%) | 0% | 171.7 | 763,346 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 169.22 per share. | 20 Aug 2024 | 6,223 | 57,319 (0%) | 0% | 169.2 | 1,053,050 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 16 | 136 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 15,971 | 63,437 (0%) | 0% | 0 | Common Stock | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 783 | 783 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 103 | 4,351 | - | - | Series A Preferred Stock | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 17 | 119 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 16 | 101 | - | - | Restricted Stock Units | |
| Abbvie Inc | Jennifer L. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,322 | 1,322 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Procter & Gamble Co. | L. Davis Jennifer | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 47 | 743 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Davis Jennifer L. | CEO - Health Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 151.23 per share. | 06 Dec 2023 | 47 | 47,255 (0%) | 0% | 151.2 | 7,108 | Common Stock |
| Procter & Gamble Co. | Davis L. Jennifer | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 151.23 per share. | 06 Dec 2023 | 47 | 47,303 (0%) | 0% | 151.2 | 7,108 | Common Stock |
| Procter & Gamble Co. | L. Davis Jennifer | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 17 | 85 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 52,251 | 52,251 | - | - | Stock Option (Right to Buy) | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 152.85 per share. | 17 Aug 2023 | 5,761 | 47,148 (0%) | 0% | 152.8 | 880,546 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 12,843 | 52,909 (0%) | 0% | 0 | Common Stock | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2023 | 12 | 67 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 791 | 791 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 108 | 4,247 | - | - | Series A Preferred Stock | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 12 | 55 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 155.27 per share. | 24 Apr 2023 | 23,943 | 39,860 (0%) | 0% | 155.3 | 3,717,630 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.52 per share. | 24 Apr 2023 | 23,943 | 63,803 (0%) | 0% | 78.5 | 1,880,004 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2023 | 23,943 | 0 | - | - | Stock Option (Right to Buy) | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 13 | 43 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 151.08 per share. | 07 Dec 2022 | 37 | 39,786 (0%) | 0% | 151.1 | 5,590 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 151.08 per share. | 07 Dec 2022 | 37 | 39,749 (0%) | 0% | 151.1 | 5,590 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 37 | 585 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2022 | 13 | 29 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 29,198 | 29,198 | - | - | Stock Option (Right to Buy) | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 6,746 | 39,640 (0%) | 0% | 0 | Common Stock | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 147.95 per share. | 23 Aug 2022 | 27,809 | 32,894 (0%) | 0% | 148.0 | 4,114,342 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2022 | 27,809 | 0 | - | - | Stock Option (Right to Buy) | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 91.07 per share. | 23 Aug 2022 | 27,809 | 60,703 (0%) | 0% | 91.1 | 2,532,566 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 19,021 | 40,515 (0%) | 0% | 0 | Common Stock | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Sale of securities on an exchange or to another person at price $ 149.33 per share. | 16 Aug 2022 | 7,621 | 32,894 (0%) | 0% | 149.3 | 1,138,039 | Common Stock |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 8 | 16 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 623 | 623 | - | - | Restricted Stock Units | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 115 | 4,138 | - | - | Series A Preferred Stock | |
| Procter & Gamble Co. | Jennifer L. Davis | CEO - Health Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 8 | 8 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges